• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of anti-HCV therapy the regulation of NS5A function

Research Project

Project/Area Number 12557053
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Gastroenterology
Research InstitutionTokyo Medical and Dental Uniersity

Principal Investigator

ENOMOTO Nobuyuki  Tokyo Medical and Dental Uniersity, Department of Gastroenterology and Hepatology, Assistant professor, 医学部附属病院, 講師 (20251530)

Co-Investigator(Kenkyū-buntansha) KUROSAKI Masayuki  Tokyo Medical and Dental Uniersity, Department of Gastroenterology and Hepatology, Instructor, 医学部附属病院, 助手 (10280976)
Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥11,700,000 (Direct Cost: ¥11,700,000)
Fiscal Year 2002: ¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 2001: ¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 2000: ¥4,100,000 (Direct Cost: ¥4,100,000)
KeywordsNS5A / HCV / Interferon / apoptosis / TNF alpha / signal transduction / chronic hepatitis / replicon / C型肝炎 / Interferon / apoptosis
Research Abstract

Hepatitis C virus (HCV) subgenomic replicon has been reported to replicate efficiently and continuously in human hepatoma Huh-7 cells. To extend the previous results to other isolated HCV clones, we have constructed another HCV replicon from HC-J4, one of the chimpanzee-infectious clones. An HCV-replicon derived from HC-J4 (RpJ4) consists of HCV-5'-UTR, neomycin phosphotransferase gene, the encephalomyocarditis virus IRES, HCV-nonstructural region, NS3 to NS5B, and HCV-3'-UTR. The adaptive mutations known to be required for HCV-Conl replicon were introduced in RpJ4 replicon, aa.(amino acids number according to HC-J4) 2197 serine to proline, deletion of serine at aa.2201, and aa.2204 serine to isoleucine (RpJ4-S2I97P, RpJ4-S22001del, and RpJ4-S2204I). RpJ4/ISDRmutant and RpJ4-S2201del/ISDRmutant were also constructed by introducing six amino acid mutations into the interferon sensitivity determining region (ISDR). Replicon RNA was transfected into Huh-7 cells, and stable replicon-expressing cell lines were established by G418 selection. After transfection to naive Huh-7 cells, RpJ4 and RpJ4/ISDRmutants did not produce any G418-resistant colonies. In contrast, G418-resistant cells were transduced efficiently by RpJ4-S2197P, RpJ4-S2204I, RpJ4-S2201del and RpJ4-S2201del/ISDRmutants, with the RpJ4-S2201del/ISDRmutant being most efficient. In conclusion, The HCV replicon derived from HC-J4 can replicate efficiently following the introduction of adaptive mutations into the upstream region of ISDR. Moreover, additional introduction of mutations into ISDR further enhances its replication. These findings demonstrate that the genetic structure of the NS5A domain is critical in HCV-1b replications.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Itakura, J, Enomoto, N, et al.: "CD81 Nucleotide Mutation in Hepatocellular Carcinoma and No CD81 Polymorphism in Patients with Various Stages of Hepatitis C Virus Infection"J Med Virol. 63. 22-28 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagayama, K, Enomoto, N, et al.: "Sequences in the NS5A Protein of Genotype 1b Hepatitis C Virus and the Serum ALT Response to Interferon Therapy in Japanese Patients"Gut. 48. 830-835 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe, H, Enomoto, N, et al.: "Number and Position of Mutations in the Interferon Sensitivity-Determining Region of the Gene for Nonstructural Protein 5A Correlates with Interferon Efficacy in Hepatitis C Virus Genotype 1b Infection"J Infect Dis. 183. 1195-1203 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagayama, K, Enomoto, N, et al.: "Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization"Am J Gastroenterol. 96. 2211-2217 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagayama N, Kurosaki M, Enomoto N, Miyasaka Y, Marumo F, Sato C: "Chracteristics of hepatitis C viral genome associated with disease progression"Hepatology. 31. 745-750 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Maekawa S, Enomoto N, Kurosaki M, Nagayama K, Sato C, Marumo F: "Genetic changes of interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C"J Med Virol. 61. 303-310 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yu S-H, Nagayama K, Enomoto N, Izumi N, Marumo F, Sato C.: "Intrahepatic mRNA expression of interferon-gamma inducible antiviral genes in liver diseases : PKR overexpression and RNase L inhibitor suppression in chronic hepatitis C"Hepatology. 32. 1089-1095 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C.: "Hepatocellular Carcinoma and No CD81 Polymorphism in Patients with Various Stages of Hepatitis C Virus Infection"J Med Virol. 63. 22-28 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagayama K, Enomoto N, Izumi N, Kurosaki M, Miyasaka Y, Watanabe H, Itakura J, Chen C-H, Tazawa J, Ikeda T, Marumo F, Sato C.: "Sequences in the NS5A Protein of Genotype 1b Hepatitis C Virus and the Serum ALT Response to Interferon Therapy in Japanese Patients"Gut. 48. 830-835 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe H, Enomoto N, Nagayama K, Izumi N, Marumo F, Sato C, Watanabe M.: "Number and Position of Mutations in the Interferon Sensitivity-Determining Region of the Gene for Nonstructural Protein 5A Correlates with Interferon Efficacy in Hepatitis C Virus Genotype 1b Infection"J Infect Dis. 183. 1195-1203 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nagayama K, Enomoto N, Miyasaka Y, Kurosaki M, Chen CH, Sakamoto N, Nakagawa M, Sato C, Tazawa J, Ikeda T, Izumi N, Watanabe M.: "Overexpression of interferon gamma-inducible protein 10 in the liver of patients with type I autoimmune hepatitis identified by suppression subtractive hybridization"Am J Gastroenterol.. 96. 2211-2217 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe H, Nagayama K, Enomoto N, Itakura J, Tanabe Y, Hamano K, Izumi N, Sato C, Watanabe M.: "Sequence element correlating with circulating viral load in genotype 1b hepatitis C virus infection"Virology. in press. (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi